Archer Investment Corp Exelixis, Inc. Transaction History
Archer Investment Corp
- $343 Billion
- Q2 2024
A detailed history of Archer Investment Corp transactions in Exelixis, Inc. stock. As of the latest transaction made, Archer Investment Corp holds 500 shares of EXEL stock, worth $13,120. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500
Previous 500
-0.0%
Holding current value
$13,120
Previous $11.9 Million
5.31%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding EXEL
# of Institutions
460Shares Held
240MCall Options Held
2.04MPut Options Held
1.29M-
Black Rock Inc. New York, NY33.5MShares$879 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.7MShares$778 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA27.1MShares$711 Million2.95% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.2MShares$398 Million0.6% of portfolio
-
State Street Corp Boston, MA12.6MShares$331 Million0.01% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $8.44B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...